Hate the needle? Oral coronavirus vaccination could turn out to be the best protection against COVID-19 and mutations … that’s hopeful one of the LA Lakers owners.
Dr. Patrick Soon-Shiong It is ImmunityBio founder and co-owner of Lakers, and his company is behind testing at a research center in El Segundo, CA, to determine if a pill can replace injections to vaccinate populations.
Researchers are experimenting with healthy volunteers under 55 who have not yet been infected with the coronavirus … by taking pictures, some were given capsules and some were given combos.
Dr Soon-Shiong said the value of ImmunityBio’s vaccine is to produce “killer T cells” that target the center of the coronavirus, which are less prone to mutations. Today’s vaccines make antibodies against the sharp part of the virus on the surface.
Although the researchers hope that oral T-cell formation methods may result in greater protection against COVID … Lakers co-owners believe that synergistic capsules and injections are key. Sorry, needle-hater.
It may take some time before we find that the oral vaccine is only experimental and that test subjects will be closely monitored over the next 12 months.